Futura Medical is a pharmaceutical company that specializes in developing innovative products using their proprietary transdermal DermaSys® technology. With a focus on sexual health and pain relief, Futura Medical is dedicated to creating differentiated and valuable solutions while minimizing risk. As experts in transdermal delivery, Futura Medical has a proven track record of successful Research & Development projects.

Their portfolio includes MED3000, a product with promising clinical potential, and a range of pain relief products such as CBD100 and TPR100. Futura Medical's strategic approach is driven by a highly skilled Board of Directors who are committed to delivering long-term value to shareholders. Through their dedication and advanced technology, Futura Medical aims to transform the healthcare industry and improve the lives of individuals worldwide.

For more information about their products, including FAQs and clinical data, investors and stakeholders can visit the Investor Centre on their website. Futura Medical is constantly pushing the boundaries of medical innovation, all while prioritizing accessibility, privacy, and the highest standards of quality